GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (OTCPK:NRXBF) » Definitions » Change In Prepaid Assets

NRXBF (NurExone Biologic) Change In Prepaid Assets : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NurExone Biologic Change In Prepaid Assets?

NurExone Biologic's Change In Prepaid Assets for the quarter that ended in Sep. 2024 was $0.00 Mil. It means NurExone Biologic's Prepaid Assets stayed the same from Jun. 2024 to Sep. 2024 .

NurExone Biologic's Change In Prepaid Assets for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means NurExone Biologic's Prepaid Assets stayed the same from Dec. 2022 to Dec. 2023 .

NurExone Biologic Change In Prepaid Assets Historical Data

The historical data trend for NurExone Biologic's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NurExone Biologic Change In Prepaid Assets Chart

NurExone Biologic Annual Data
Trend Dec21 Dec22 Dec23
Change In Prepaid Assets
- - -

NurExone Biologic Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NurExone Biologic Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NurExone Biologic Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of NurExone Biologic's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

NurExone Biologic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (OTCPK:NRXBF) » Definitions » Change In Prepaid Assets
Comparable Companies
TSX:HBP TSX:MBX XCNQ:GLAB NEOE:BMND TSX:BCT XCNQ:DTC TSXV:MIR TSXV:GSD TSXV:TTI XCNQ:DOSE VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
J90:Germany NRX:Canada
Address
1 Adelaide St. East, Suite 801, Toronto, ON, CAN, M5C 2V9
Website
https://www.nurexone.com
NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.